跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目281-290 / 12927. (共1293頁) << < 24 25 26 27 28 29 30 31 32 33 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	European Journal of Cancer. 2022 Sep;173:123-132.
2015-11	A prospective study of alcohol advertisement on alcohol experiences among adolescents in Taiwan	Drug and Alcohol Dependence. 2015 Nov;156:Abstract number e100.
2019-08-12	A prospective study of the factors associated with life quality during medical internship	PLoS ONE. 2019 Aug 12;14(8):Article number e0220608.
2020-11	A pseudolikelihood approach for assessing genetic association in case-control studies with unmeasured population structure	Statistical Methods in Medical Research. 2020 Nov;29(11):3153-3165.
2023-06-12	A qualitative study of nonagenarians and centenarians living in Taiwan	IAGG Asia and Oceania Regional Congress 2023. 2023 Jun 12-14.
2023-08	A randomised trial comparing drug-coated balloons and conventional balloons for the treatment of stent-graft stenosis in dialysis vascular access	European Journal of Vascular and Endovascular Surgery. 2023 Aug;66(2):253-260.
2020-06	A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts	Journal of Vascular Surgery. 2020 Jun;71(6):1994-2003.
2019-10	A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FO	Annals of Oncology. 2019 Oct;30(Suppl. 5):321.
2019-07-31	A randomized feasibility study of the effect of ascorbic acid on post-angioplasty restenosis of hemodialysis vascular access (NCT03524846)	Scientific Reports. 2019 Jul 31;9:Article number 11095.
2017-08	A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo	Cancer Chemotherapy and Pharmacology. 2017 Aug;80(2):307-315.

顯示項目281-290 / 12927. (共1293頁) << < 24 25 26 27 28 29 30 31 32 33 > >> 每頁顯示[10|25|50]項目